Low-dose recombinant factor VIIa for reversing coagulopathy in patients with isolated traumatic brain injury

Journal of Critical Care

Volumn 30, Issue 1, 2015, Pages 116-120

  Yuan, Qiang ^a   Wu, Xing ^a   Du, Zhuo Ying ^a   Sun, Yi Rui ^a   Yu, Jian ^a   Li, Zhi Qi ^a   Wu, Xue Hai ^a   Mao, Ying ^a   Zhou, Liang Fu ^a   Hu, Jin ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Coagulopathy; Recombinant factor VIIa; Traumatic brain injury

Indexed keywords

FIBRINOGEN; FRESH FROZEN PLASMA; HEMOGLOBIN; LACTIC ACID; PLASMIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 7A; COAGULATING AGENT; RECOMBINANT FVIIA; RECOMBINANT PROTEIN;

ADOLESCENT; ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLOOD CLOTTING DISORDER; BRAIN INFARCTION; CONSERVATIVE TREATMENT; CONTROLLED STUDY; CRYOPRECIPITATE; DECOMPRESSIVE CRANIECTOMY; DEEP VEIN THROMBOSIS; ERYTHROCYTE TRANSFUSION; FEMALE; FIBRINOGEN BLOOD LEVEL; GLASGOW OUTCOME SCALE; HEART ARREST; HEART INFARCTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; INCIDENCE; INJURY; INTENSIVE CARE UNIT; INTERNATIONAL NORMALIZED RATIO; INTRACRANIAL PRESSURE MONITORING; LACTATE BLOOD LEVEL; LENGTH OF STAY; LOW DRUG DOSE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; PARTIAL THROMBOPLASTIN TIME; PLASMA TRANSFUSION; PROGRESSIVE HEMORRHAGIC INJURY; PROSPECTIVE STUDY; SINGLE DRUG DOSE; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; TRAUMATIC BRAIN INJURY; BLOOD; BLOOD CLOTTING; BLOOD COAGULATION DISORDERS; BRAIN INJURY; GLASGOW COMA SCALE; HEMORRHAGE; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; PHYSIOLOGY; THROMBOEMBOLISM;

ADULT; BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; BRAIN INJURIES; COAGULANTS; FACTOR VIIA; FEMALE; GLASGOW COMA SCALE; GLASGOW OUTCOME SCALE; HEMORRHAGE; HUMANS; INJECTIONS, INTRAVENOUS; INTENSIVE CARE UNITS; INTERNATIONAL NORMALIZED RATIO; LENGTH OF STAY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; THROMBOEMBOLISM;

EID: 84920665185     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2014.07.009     Document Type: Article

References (40)

1. Summers C.R., Ivins B., Schwab K.A. Traumatic brain injury in the United States: an epidemiologic overview. Mt Sinai J Med 2009, 76:105-110.
2. Harhangi B.S., Kompanje E.J., Leebeek F.W., Maas A.I. Coagulation disorders after traumatic brain injury. Acta Neurochir (Wien) 2008, 150:165-175. [discussion 175].
3. Hoyt D.B. A clinical review of bleeding dilemmas in trauma. Semin Hematol 2004, 41:40-43.
4. Sun Y., Wang J., Wu X., Xi C., Gai Y., Liu H., et al. Validating the incidence of coagulopathy and disseminated intravascular coagulation in patients with traumatic brain injury-analysis of 242 cases. Br J Neurosurg 2011, 25:363-368.
5. Kumura E., Sato M., Fukuda A., Takemoto Y., Tanaka S., Kohama A. Coagulation disorders following acute head injury. Acta Neurochir (Wien) 1987, 85:23-28.
6. van der Sande J.J., Veltkamp J.J., Boekhout-Mussert R.J., Bouwhuis-Hoogerwerf M.L. Head injury and coagulation disorders. J Neurosurg 1978, 49:357-365.
7. Vecht C.J., Sibinga C.T., Minderhoud J.M. Disseminated intravascular coagulation and head injury. J Neurol Neurosurg Psychiatry 1975, 38:567-571.
8. Olson J.D., Kaufman H.H., Moake J., O'Gorman T.W., Hoots K., Wagner K., et al. The incidence and significance of hemostatic abnormalities in patients with head injuries. Neurosurgery 1989, 24:825-832.
9. Wafaisade A., Lefering R., Tjardes T., Wutzler S., Simanski C., Paffrath T., et al. Acute coagulopathy in isolated blunt traumatic brain injury. Neurocrit Care 2010, 12:211-219.
10. Faringer P.D., Mullins R.J., Johnson R.L., Trunkey D.D. Blood component supplementation during massive transfusion of AS-1 red cells in trauma patients. J Trauma 1993, 34:481-485. [discussion 485-487].
11. Etemadrezaie H., Baharvahdat H., Shariati Z., Lari S.M., Shakeri M.T., Ganjeifar B. The effect of fresh frozen plasma in severe closed head injury. Clin Neurol Neurosurg 2007, 109:166-171.
12. Khan H., Belsher J., Yilmaz M., Afessa B., Winters J.L., Moore S.B., et al. Fresh-frozen plasma and platelet transfusions are associated with development of acute lung injury in critically ill medical patients. Chest 2007, 131:1308-1314.
13. Bochicchio G.V., Napolitano L., Joshi M., Bochicchio K., Meyer W., Scalea T.M. Outcome analysis of blood product transfusion in trauma patients: a prospective, risk-adjusted study. World J Surg 2008, 32:2185-2189.
14. Dara S.I., Rana R., Afessa B., Moore S.B., Gajic O. Fresh frozen plasma transfusion in critically ill medical patients with coagulopathy. Crit Care Med 2005, 33:2667-2671.
15. Dutton R.P., Hess J.R., Scalea T.M. Recombinant factor VIIa for control of hemorrhage: early experience in critically ill trauma patients. J Clin Anesth 2003, 15:184-188.
16. Dutton R.P., McCunn M., Hyder M., D'Angelo M., O'Connor J., Hess J.R., et al. Factor VIIa for correction of traumatic coagulopathy. J Trauma 2004, 57:709-718. [discussion 718-709].
17. Morey A.F. Factor VIIa for correction of traumatic coagulopathy. J Urol 2005, 174:968.
18. Eikelboom J.W., Bird R., Blythe D., Coyle L., Gan E., Harvey M., et al. Recombinant activated factor VII for the treatment of life-threatening haemorrhage. Blood Coagul Fibrinolysis 2003, 14:713-717.
19. Boffard K.D., Riou B., Warren B., Choong P.I., Rizoli S., Rossaint R., et al. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma 2005, 59:8-15. [discussion 15-18].
20. Kenet G., Walden R., Eldad A., Martinowitz U. Treatment of traumatic bleeding with recombinant factor VIIa. Lancet 1999, 354:1879.
21. O'Connell N.M., Perry D.J., Hodgson A.J., O'Shaughnessy D.F., Laffan M.A., Smith O.P. Recombinant FVIIa in the management of uncontrolled hemorrhage. Transfusion 2003, 43:1711-1716.
22. Khan A.Z., Parry J.M., Crowley W.F., McAllen K., Davis A.T., Bonnell B.W., et al. Recombinant factor VIIa for the treatment of severe postoperative and traumatic hemorrhage. Am J Surg 2005, 189:331-334.
23. Geeraedts L.M., Kamphuisen P.W., Kaasjager H.A., Verwiel J.M., van Vugt A.B., Frolke J.P. The role of recombinant factor VIIa in the treatment of life-threatening haemorrhage in blunt trauma. Injury 2005, 36:495-500.
24. Hoffman M., Monroe D.M. Tissue factor in brain is not saturated with factor VIIa: implications for factor VIIa dosing in intracerebral hemorrhage. Stroke 2009, 40:2882-2884.
25. Mayer S.A., Brun N.C., Begtrup K., Broderick J., Davis S., Diringer M.N., et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2008, 358:2127-2137.
26. Stein D.M., Dutton R.P., Hess J.R., Scalea T.M. Low-dose recombinant factor VIIa for trauma patients with coagulopathy. Injury 2008, 39:1054-1061.
27. Lustenberger T., Talving P., Kobayashi L., Barmparas G., Inaba K., Lam L., et al. Early coagulopathy after isolated severe traumatic brain injury: relationship with hypoperfusion challenged. J Trauma 2010, 69:1410-1414.
28. Bratton S.L., Chestnut R.M., Ghajar J., McConnell Hammond F.F., Harris O.A., Hartl R., et al. Guidelines for the management of severe traumatic brain injury: IX. Cerebral perfusion thresholds. J Neurotrauma 2007, 24(Suppl. 1):S59-S64.
29. Bratton S.L., Chestnut R.M., Ghajar J., McConnell Hammond F.F., Harris O.A., Hartl R., et al. Guidelines for the management of severe traumatic brain injury: VIII. Intracranial pressure thresholds. J Neurotrauma 2007, 24(Suppl. 1):S55-S58.
30. Bratton S.L., Chestnut R.M., Ghajar J., McConnell Hammond F.F., Harris O.A., Hartl R., et al. Guidelines for the management of severe traumatic brain injury: VI. Indications for intracranial pressure monitoring. J Neurotrauma 2007, 24(Suppl. 1):S37-S44.
31. Allard C.B., Scarpelini S., Rhind S.G., Baker A.J., Shek P.N., Tien H., et al. Abnormal coagulation tests are associated with progression of traumatic intracranial hemorrhage. J Trauma 2009, 67:959-967.
32. Howes J.L., Smith R.S., Helmer S.D., Taylor S.M. Complications of recombinant activated human coagulation factor VII. Am J Surg 2009, 198:895-899.
33. Simpson E., Lin Y., Stanworth S., Birchall J., Doree C., Hyde C. Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia. Cochrane Database Syst Rev 2012, 3:CD005011.
34. Andersen N.D., Bhattacharya S.D., Williams J.B., Fosbol E.L., Lockhart E.L., Patel M.B., et al. Intraoperative use of low-dose recombinant activated factor VII during thoracic aortic operations. Ann Thorac Surg 2012, 93:1921-1928. [discussion 1928-1929].
35. Epstein D.S., Mitra B., O'Reilly G., Rosenfeld J.V., Cameron P.A. Acute traumatic coagulopathy in the setting of isolated traumatic brain injury: a systematic review and meta-analysis. Injury 2014, 45:819-824.
36. Karadimov D., Binev K., Nachkov Y., Platikanov V. Use of activated recombinant Factor VII (NovoSeven) during neurosurgery. J Neurosurg Anesthesiol 2003, 15:330-332.
37. Hawryluk G.W., Cusimano M.D. The role of recombinant activated factor VII in neurosurgery: hope or hype?. J Neurosurg 2006, 105:859-868.
38. Stein D.M., Dutton R.P., Kramer M.E., Scalea T.M. Reversal of coagulopathy in critically ill patients with traumatic brain injury: recombinant factor VIIa is more cost-effective than plasma. J Trauma 2009, 66:63-72. [discussion 73-65].
39. Narayan R.K., Maas A.I., Marshall L.F., Servadei F., Skolnick B.E., Tillinger M.N. Recombinant factor VIIA in traumatic intracerebral hemorrhage: results of a dose-escalation clinical trial. Neurosurgery 2008, 62:776-786. [discussion 786-778].
40. Perel P., Arango M., Clayton T., Edwards P., Komolafe E., Poccock S., et al. Predicting outcome after traumatic brain injury: practical prognostic models based on large cohort of international patients. BMJ 2008, 336:425-429.